Hudson Frederick M.
SEC Form 4 insider trading activity
Hudson Frederick M. has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Mar 16, 2026.
On the most recent filing, Hudson Frederick M. is listed as Director at SUPERNUS PHARMACEUTICALS, INC. Inside the rolling window, Hudson Frederick M. reported no open-market purchases and 1 open-market sale totaling $272K in SUPN.
Companies traded
Other insiders at SUPN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$272K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hudson Frederick M. made?
Hudson Frederick M. has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Hudson Frederick M. trade?
Hudson Frederick M. has filed SEC Form 4 disclosures for 1 company, including SUPN.
When was Hudson Frederick M.'s most recent SEC Form 4 filing?
Hudson Frederick M.'s most recent SEC Form 4 filing on Tracefour is dated Mar 16, 2026.
What is Hudson Frederick M.'s total buy and sell value in the current window?
Inside the rolling retention window, Hudson Frederick M. bought $0 and sold $272K based on SEC Form 4 filings.
What was Hudson Frederick M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,369 SUPN shares on 2026-03-12, worth $272K, per SEC Form 4 filings.